Concepedia

Author

Juergen Kuschyk

University Medical Centre MannheimORCID

Also Known As

F Fastenrath, J K Kuschyk, J Kuschyk, J. Kuschyk, Juergen Kuschyk, Juergen Kuschyk (586549), Kuschyk, J, L. Geller, L. Tavazzi, M. Trusz-Gluza

88

Publications

2K

Citations

18

H-Index

28

Concepts

All Affiliations

University Medical Centre MannheimHeidelberg UniversityUniversity Hospital HeidelbergGerman Centre for Cardiovascular ResearchUniversity of Mannheim
JK

About

Juergen Kuschyk is an author at University Medical Centre Mannheim specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

416

2

Emergency Medicine

3

3

153

3

Health Sciences

2

2

30

4

Kinesiology

1

1

12

5

Pharmacology

1

1

190

Juergen Kuschyk

×

20

Publications

1.9K

Citations

18

H-Index

YearCitations

Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

Gaetano Maria De Ferrari, Harry J.G.M. Crijns, Martin Borggrefe,

European Heart Journal

2010

519

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry

Lucas V.A. Boersma, Craig Barr, Reinoud E. Knops,

Journal of the American College of Cardiology

2017

323

Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome

Christian Wolpert, Constanze Echternach, Christian Veltmann,

Heart Rhythm

2005

190

A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification

Christian Veltmann, Rainer Schimpf, Constanze Echternach,

European Heart Journal

2006

190

Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial

Reinoud E. Knops, Shari Pepplinkhuizen, Peter Paul H.M. Delnoy,

European Heart Journal

2022

85

Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges

Christian Veltmann, C. Wolpert, Frédéric Sacher,

EP Europace

2009

81

Insights into the location of type I ECG in patients with Brugada syndrome: Correlation of ECG and cardiovascular magnetic resonance imaging

Christian Veltmann, Theano Papavassiliu, Torsten Konrad,

Heart Rhythm

2011

77

Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing

Anne‐Floor B.E. Quast, Sarah W.E. Baalman, Timothy R. Betts,

American Heart Journal

2019

58

Prevention of inappropriate ICD shocks in patients with Brugada syndrome

Christian Veltmann, Juergen Kuschyk, Rainer Schimpf,

Clinical Research in Cardiology

2009

52

Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: An Analysis of All Appropriate Therapy in the PRAETORIAN trial

Reinoud E. Knops, Willeke van der Stuijt, Juergen Kuschyk,

UCL Discovery (University College London)

2021

46

Page 1